Comparing the Responsiveness of Epigenetic Aging Biomarkers
Key claim: A recent study evaluated and compared how responsive several DNA methylation (DNAm) aging biomarkers are to a range of longevity interventions.
Abstract
In a recent study, researchers have evaluated how responsive several DNA methylation (DNAm) biomarkers are to a range of longevity […]
Why this matters
Choosing which epigenetic clock to run is not neutral: clocks differ in how much they move under the same intervention, and a ‘responsive’ clock may just be a noisier one. A head-to-head responsiveness comparison is the kind of methodological benchmarking this area needs before intervention trials can credibly claim to ‘lower biological age’ — but responsiveness is not the same as outcome validity, and movement in a clock is still not proof of de-aging.